Important legal notice
Contact   |   Search on Europa   

Infectious Diseases Graphic element print icon Graphic element
  Homepage
Graphic element General information
  RTD Infectious Diseases Unit
  Developing countries
  EDCTP
   
Graphic element Projects
  About FP6 Funding
  FP6 projects
  About FP5 Funding
  FP5 projects
   
   
Graphic element Addressed Diseases
  HIV/AIDS
- News
  Malaria
  Tuberculosis
   
Graphic element Calls for proposals
  FP7 Calls
   
Graphic element Contact corner
  Unit
  Scientific officers
  Subscribe to our mailing list
   
 
no acronym
HIV/AIDS (INCO)
Framework programme: 5
Project number:
IC18-CT98-0380
EC contribution: € 1 000 000
Duration: 36 months
Type: RS
Starting date: 1 December 1998
Graphic element Collaboration on Vaginal Microbicides Development for the Prevention of HIV Transmission
Keywords: HIV

Summary:

The objective of the project is the prevention of heterosexual transmission of HIV through the development and use of vaginal microbicides.

Description:

The goals of the project are:

1) To conduct and to publish the results of a Ugandan phase II, randomised, placebo-controlled study of the candidate microbicides Dextrin Sulphate and PRO 2000. The safety, tolerability and acceptability of these agents will be assessed in sexually active women attending St Francis Hospital, Nsambya, Kampala using the gels for a period of one month.

2) To determine the suitability of these vaginal microbicides for phase III studies. The safety and acceptability data from the successful completion of the placebo-controlled phase II safety study will enable the partners to select suitable agent(s) for phase III safety, tolerability and efficacity studies.

3) To prepare the African site for phase III studies of vaginal microbicides. The infrastructure of the developing country (DC) site will be prepared for phase III studies of vaginal microbicides by the transfer of technology, the development of local skills through workshops, the experience gained through conducting the phase II study and by the upgrading of local facilities.

4) To conduct a third part of a phase I study of Dextrin sulphate to explore the phenomenon of vaginal bleeding.

5) To conduct laboratory studies on cervico-vaginal lavages (CVLs) from a phase I study of Dextrin sulphate to evaluate cytokines and HIV-RNA.

Coordinator:

Charles LACEY
Imperial College of Science, Technology and Medicine
Department of Genito-Urinary Medicine and Communicable Diseases
Imperial College School of Medicine at St Mary’s, Norfolk Place
UK-W2 1PG London
United Kingdom
Tel: +44 171 8861539
Fax: +44 171 8866645
E-mail: charles.lacey@ic.ac.uk

Partners:

  1. Marie Laga, Prince Leopold Institute for Tropical Medicine, STD/HIV Research and Intervention Unit, Department of Microbiology, BE-Antwerp, Belgium
  2. Jan Balzarini, Katholieke Universiteit Leuven, Afdeling Virologie en Chemotherapie – Faculteit Geneeskunde, Departement Microbiologie en Immunologie, BE-Leuven, Belgium
  3. Jag Whitworth, Uganda Virus Research Institute, Medical Research Council Programme on Aids, Entebbe, Uganda
  4. Peter Ghys and I.M. Coulibaly, Programme National de Lutte Contre Le Sida, Les MST et La Tuberculose, Abidjan, Ivory Coast

 
 
top
Graphic element